These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9244634)

  • 1. [Parkinsonian syndromes in children].
    Chutorian A
    Rev Neurol; 1997 Jun; 25(142):954-65. PubMed ID: 9244634
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical picture and treatment of Parkinson-like syndromes of hereditary etiology].
    Markova ED; Ivanova-Smolenskaia IA; Insarova NG; Barkhatova VP
    Klin Med (Mosk); 1978 Sep; 56(9):104-11. PubMed ID: 151762
    [No Abstract]   [Full Text] [Related]  

  • 3. [Atypical Parkinsonian syndromes, a challenging group of diseases].
    Liimatainen S; Haapasalo H; Kähärä V; Paetau A; Honkaniemi J
    Duodecim; 2005; 121(16):1757-66. PubMed ID: 16268222
    [No Abstract]   [Full Text] [Related]  

  • 4. Autosomal recessive juvenile Parkinson's disease with partial trisomy of chromosome 6q syndrome: a case report.
    Namihira T; Hattori N; Shiroma S; Miyazato Y
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):672-3. PubMed ID: 15601396
    [No Abstract]   [Full Text] [Related]  

  • 5. Extreme anticipation in young-onset Parkinson's disease.
    Djaldetti R; Ziv I; Melamed E
    Mov Disord; 1998 May; 13(3):599-600. PubMed ID: 9613762
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical aspects on juvenile parkinsonism].
    Ishikawa A
    No To Shinkei; 1994 Jun; 46(6):517-22. PubMed ID: 8068432
    [No Abstract]   [Full Text] [Related]  

  • 7. Pramipexole in Parkinson's disease. A short-term study using the combined levodopa-dopamine agonist test.
    Fabbrini G; Barbanti P; Aurilia C; Pauletti C; Meco G
    Funct Neurol; 2002; 17(4):199-201. PubMed ID: 12675263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCA2 may present as levodopa-responsive parkinsonism.
    Payami H; Nutt J; Gancher S; Bird T; McNeal MG; Seltzer WK; Hussey J; Lockhart P; Gwinn-Hardy K; Singleton AA; Singleton AB; Hardy J; Farrer M
    Mov Disord; 2003 Apr; 18(4):425-9. PubMed ID: 12671950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Parkinson disease. Early diagnosis and combined therapy improve prognosis. Report from the Symposium: "New and successful attempts at the diagnosis and therapy of Parkinson disease"].
    Fortschr Med Suppl; 1993; 150():1-7. PubMed ID: 9260319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Parkinson patients].
    Ludin HP
    Praxis (Bern 1994); 2001 Jun; 90(23):1007. PubMed ID: 11447719
    [No Abstract]   [Full Text] [Related]  

  • 11. [Parkinson disease: physiopathology and therapy. Differential diagnosis of Parkinson disease].
    Nervenarzt; 1995 Sep; 66(9 Suppl Morbus):1-4. PubMed ID: 9131092
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical analysis of 15 cases of Dopa-responsive dystonia].
    Yang J; Yuan XQ; Xiao L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):725-6. PubMed ID: 16114571
    [No Abstract]   [Full Text] [Related]  

  • 13. [If I were to wake-up clumsy and trembling...(or how to begin treatment of Parkinson disease].
    Linazasoro G
    Neurologia; 1998; 13(6):265-70. PubMed ID: 9734197
    [No Abstract]   [Full Text] [Related]  

  • 14. A case of levodopa-responsive camptocormia associated with advanced Parkinson's disease.
    Ho B; Prakash R; Morgan JC; Sethi KD
    Nat Clin Pract Neurol; 2007 Sep; 3(9):526-30. PubMed ID: 17805247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease.
    Jowi JO
    East Afr Med J; 2008 Jan; 85(1):1-2. PubMed ID: 18543519
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions.
    Wilcox RA; Churchyard A; Dahl HH; Hutchison WM; Kirby DM; Thyagarajan D
    Mov Disord; 2007 May; 22(7):1020-3. PubMed ID: 17357142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa therapeutics for Parkinson's disease: new developments.
    LeWitt PA
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease.
    Deleu D; Jacob P; Chand P; Sarre S; Colwell A
    Neurology; 2006 Sep; 67(5):897-9. PubMed ID: 16966563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Idiopathic Parkinson's disease].
    Vieregge P
    Fortschr Neurol Psychiatr; 2008 Feb; 76(2):114-22; quiz 123-6. PubMed ID: 18256971
    [No Abstract]   [Full Text] [Related]  

  • 20. [Parkinson disease].
    Moore AP; Clarke CE
    Praxis (Bern 1994); 2001 Jun; 90(23):1041-6. PubMed ID: 11447724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.